Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2018-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jcb.26169PMID 28543595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MiR-21/PTEN signaling modulates the chemo-sensitivity to 5-fluorouracil in human lung adenocarcinoma A549 cells.

  2019cited by this paper
• State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia

  2018cited by this paper
• Plasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis

  2018cited by this paper
• MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer

  2018cited by this paper
• MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy

  2018cited by this paper
• NLRP3 inflammasome: Its regulation and involvement in atherosclerosis

  2018cited by this paper
• Therapeutic application of multipotent stem cells

  2018cited by this paper
• Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?

  2017influential reference
• Stroke in Women: Risk Factors and Clinical Biomarkers

  2017cited by this paper
• Macrophage Polarization: Anti‐Cancer Strategies to Target Tumor‐Associated Macrophage in Breast Cancer

  2017cited by this paper
• MicroRNAs‐Based Imaging Techniques in Cancer Diagnosis and Therapy

  2017cited by this paper
• Anti‐Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis

  2017influential reference
• Molecular Imaging and Oral Cancer Diagnosis and Therapy

  2017cited by this paper
• Therapeutic use of stem cells for cardiovascular disease

  2016cited by this paper
• Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.

  2016cited by this paper
• SiRNA and epigenetic aberrations in ovarian cancer.

  2016influential reference
• Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases.

  2016cited by this paper
• GRASP: A Multitasking Tether

  2016cited by this paper
• Mesenchymal stem cell: a new horizon in cancer gene therapy

  2016cited by this paper
• Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia

  2016cited by this paper
• Roles of FGF Signals in Heart Development, Health, and Disease

  2016cited by this paper
• New strategies for improving stem cell therapy in ischemic heart disease

  2016influential reference
• Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents.

  2016influential reference
• Concise Review: Pluripotent Stem Cell‐Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand?

  2016cited by this paper
• Glioblastoma: exosome and microRNA as novel diagnosis biomarkers

  2016cited by this paper
• Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma

  2016cited by this paper
• Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives.

  2016influential reference
• Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data

  2015cited by this paper
• Challenges in identifying the best source of stem cells for cardiac regeneration therapy

  2015influential reference
• Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial

  2015cited by this paper
• Non-Viral Methods For Generating Integration-Free, Induced Pluripotent Stem Cells

  2015cited by this paper
• Signaling molecules, transcription growth factors and other regulators revealed from in-vivo and in-vitro models for the regulation of cardiac development.

  2015cited by this paper
• Identification of Therapeutic Covariant MicroRNA Clusters in Hypoxia-Treated Cardiac Progenitor Cell Exosomes Using Systems Biology

  2015cited by this paper
• Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines

  2015cited by this paper
• Allogeneic adipose stem cell therapy in acute myocardial infarction

  2014cited by this paper
• Stem Cell Therapy for Heart Failure

  2014cited by this paper
• Autologous Transplantation of Bone Marrow Adult Stem Cells for the Treatment of Idiopathic Dilated Cardiomyopathy

  2014cited by this paper
• Atorvastatin induces autophagy of mesenchymal stem cells under hypoxia and serum deprivation conditions by activating the mitogenactivated protein kinase/extracellular signal‐regulated kinase pathway

  2014cited by this paper
• Effects of Intracoronary CD34+ Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy Patients: 5-Year Follow-Up

  2013cited by this paper
• Functional Consequences of Human Induced Pluripotent Stem Cell Therapy: Myocardial ATP Turnover Rate in the In Vivo Swine Heart With Postinfarction Remodeling

  2013cited by this paper
• Organogenesis of the vertebrate heart

  2013cited by this paper
• Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

  2013cited by this paper
• Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions

  2013influential reference
• Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair

  2013cited by this paper
• Induced Pluripotency and Oncogenic Transformation Are Related Processes

  2013cited by this paper
• Stem cell therapy for heart failure.

  2013cited by this paper
• Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

  2012cited by this paper
• Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.

  2012influential reference
• Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions

  2012cited by this paper
• The kynurenine system and immunoregulation

  2012cited by this paper
• Toward clinical application of stem cells for cardiac regeneration.

  2011cited by this paper
• Stem cell therapy for heart diseases.

  2011cited by this paper
• Bone marrow cell transplantation in Chagas' disease heart failure: report of the first human experience.

  2011cited by this paper
• Transplante de células de la médula ósea en la insuficiencia cardíaca de la enfermedad de chagas: relato de la Primera Experiencia Humana

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells.

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells

  2011cited by this paper
• Epidemiology and cost of advanced heart failure.

  2011cited by this paper
• Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart.

  2011cited by this paper
• Epidemiology and risk profile of heart failure

  2011cited by this paper
• A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.

  2011cited by this paper
• Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

  2011cited by this paper
• Current and Future Status of Stem Cell Therapy in Heart Failure

  2010cited by this paper
• Stem cells: An overview with respect to cardiovascular and renal disease

  2010cited by this paper
• Differentiation of Human Embryonic Stem Cells to Cardiomyocytes for In Vitro and In Vivo Applications

  2010cited by this paper
• Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration.

  2010cited by this paper
• Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation

  2010cited by this paper
• Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Model in Rat

  2010cited by this paper
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Cell therapy for myocardial infarction.

  2010cited by this paper
• Cell therapy for heart disease: great expectations, as yet unmet.

  2009cited by this paper
• Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Potential Myogenic Stem Cell Populations: Sources, Plasticity, and Application for Cardiac Repair

  2009influential reference
• Engraftment, Differentiation, and Functional Benefits of Autologous Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopathy

  2009cited by this paper
• Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

  2009cited by this paper
• Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure

  2009cited by this paper
• Stem cell engineering for treatment of heart diseases: Potentials and challenges

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.

  2009cited by this paper
• Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

  2008cited by this paper
• Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function

  2008influential reference
• Characteristics of "Stage D" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM).

  2008influential reference
• , Hermann Randomized Placebo-Controlled Study of Myoblast Transplantation The Myoblast Autologous Grafting in Ischemic Cardiomyopathy ( MAGIC ) Trial : First

  2008cited by this paper
• Skeletal Myoblasts Preserve Remote Matrix Architecture and Global Function When Implanted Early or Late After Coronary Ligation Into Infarcted or Remote Myocardium

  2008cited by this paper
• Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

  2008cited by this paper
• Myocardial tissue engineering.

  2008cited by this paper
• Stem-cell therapy for cardiac disease

  2008cited by this paper
• Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium.

  2007cited by this paper
• Cell therapy in myocardial infarction.

  2007cited by this paper
• The potential of cardiac stem cell therapy for heart failure.

  2007cited by this paper
• Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction.

  2007cited by this paper
• Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts.

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• CORONARY ARTERY DISEASE Original Studies Pilot Study to Evaluate the Safety and Feasibility of Intracoronary CD133 and CD133 CD34 Cell Therapy in Patients With Nonviable Anterior Myocardial Infarction

  2007cited by this paper
• Developmental Changes in Cardiomyocytes Differentiated from Human Embryonic Stem Cells: A Molecular and Electrophysiological Approach

  2007cited by this paper
• In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

  2007cited by this paper
• Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

  2007cited by this paper
• Embryonic Stem Cell Transplantation after Experimental Traumatic Brain Injury Dramatically Improves Neurological Outcome, But May Cause Tumors

  2007cited by this paper
• Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury

  2007cited by this paper

• Programmable short peptides for modulating stem cell fate in tissue engineering and regenerative medicine.

  2025cites this paper
• Differentiation properties of 3D scaffolds nanostructured with multi-walled carbon nanotubes on human induced pluripotent stem cells

  2025cites this paper
• Advances In Stem Cell Therapy for Cardiovascular Diseases

  2025cites this paper
• microRNAs shuttled by mesenchymal stromal cell-derived exosomes in coronary artery disease: A systematic review of preclinical studies

  2025cites this paper
• The microenvironment in atherosclerosis: molecular regulation mechanism and immunotherapy

  2025cites this paper
• L-arginine from elder human mesenchymal stem cells induces angiogenesis and enhances therapeutic effects on ischemic heart diseases

  2025cites this paper
• Stem Cells in Regenerative Medicine: Unlocking Therapeutic Potential Through Stem Cell Therapy, 3D Bioprinting, Gene Editing, and Drug Discovery

  2025cites this paper
• Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency

  2024cites this paper
• Thrombin Immobilized on Magnetic Core-Shell Mesoporous Silica Nanoparticles for Screening of the Enzyme Inhibitors From Notopterygium Incisum.

  2024cites this paper
• Clinical application and immune infiltration landscape of stemness‐related genes in heart failure

  2024cites this paper
• Mechanistic exploration of the Shenlian formula in the suppression of atherosclerosis progression via network pharmacology and in vivo experimental validation.

  2024cites this paper
• Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: Promises, problems and prospects

  2023cites this paper
• Principle and design of clinical efficacy observation of extracorporeal cardiac shock wave therapy for patients with myocardial ischemia-reperfusion injury: A prospective randomized controlled trial protocol

  2023cites this paper
• Mesenchymal Stem Cell-Derived Exosomes and Their MicroRNAs in Heart Repair and Regeneration

  2023cites this paper
• The role of cardiac resident macrophage in cardiac aging

  2023cites this paper
• Bone marrow mesenchymal stem cellsderived exosomes stabilize atherosclerosis through inhibiting pyroptosis

  2023cites this paper
• Combinatorial Nutraceutical Supplement Pill (CNSP) activates naïve adult telomerase positive stem cells in-situ to heal cardiomyopathies

  2023cites this paper
• Investigation of impacts of decellularized heart extracellular matrix and VEGF on cardiomyogenic differentiation of mesenchymal stem cell through Notch/Hedgehog signaling pathways.

  2023cites this paper
• Allogeneic Adipose-Derived Mesenchymal Stem Cell Transplantation Alleviates Atherosclerotic Plaque by Inhibiting Ox-LDL Uptake, Inflammatory Reaction and Endothelial Damage in Rabbits

  2023cites this paper
• Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?

  2023cites this paper
• Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Wogonoside on acute myocardial ischemia rats.

  2023cites this paper
• Target and Cell Therapy for Atherosclerosis and CVD

  2023cites this paper
• Dual Labeling of Primary Cells with Fluorescent Gadolinium Oxide Nanoparticles

  2023cites this paper
• Insights into the roles of IL-10-producing regulatory B cells in cardiovascular disorders: Recent advances and future perspectives.

  2023cites this paper
• Exosomes as cutting-edge therapeutics in various biomedical applications: An update on engineering, delivery, and preclinical studies.

  2023cites this paper
• Young human PRP promotes the rejuvenation of aged bone marrow mesen -chymal stem cells and the therapeutic effect on ischemic heart disease.

  2023cites this paper
• Emerging roles of macrophages in heart failure and associated treatment approaches

  2023cites this paper
• Immunogenicity of mesenchymal stromal/stem cells

  2023cites this paper
• Carbon dots as a new class of multifunctional nanomaterial in mesenchymal stem cells: opportunities and challenges.

  2023cites this paper
• Curcumin a Natural Phenol and Its Therapeutic Role in Cancer and Photodynamic Therapy: A Review

  2023cites this paper
• Hydrogel scaffolds in bone regeneration: Their promising roles in angiogenesis

  2023cites this paper
• DT-010 Exerts Cardioprotective Effects by Regulating the Crosstalk between the AMPK/PGC-1α Pathway and ERp57

  2023cites this paper
• Role of Ceramides in the Molecular Pathogenesis and Potential Therapeutic Strategies of Cardiometabolic Diseases: What we Know so Far

  2022cites this paper
• Cultivo de células troncales de médula ósea de ratas para uso en regeneración de tejidos

  2022cites this paper
• Extracorporeal Cardiac Shock Wave-Induced Exosome Derived From Endothelial Colony-Forming Cells Carrying miR-140-3p Alleviate Cardiomyocyte Hypoxia/Reoxygenation Injury via the PTEN/PI3K/AKT Pathway

  2022cites this paper
• Future regenerative medicine developments and their therapeutic applications.

  2022cites this paper
• Stem Cell-Derived Exosomes: A New Therapeutic Strategy in Regenerative Medicine

  2022cites this paper
• A Study on the Protective Effect of sRAGE-MSCs in a Rodent Reperfusion Model of Myocardial Infarction

  2022cites this paper
• Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies

  2022cites this paper
• Extracellular vesicle: A magic lamp to treat skin aging, refractory wound, and pigmented dermatosis?

  2022cites this paper
• Mechanical strain drives exosome production, function, and miRNA cargo in C2C12 muscle progenitor cells

  2022cites this paper
• Mesenchymal stem cells-derived exosomes as a promising new approach for the treatment of infertility caused by polycystic ovary syndrome

  2022cites this paper
• Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics

  2022cites this paper
• Comorbidities in Androgenetic Alopecia: A Comprehensive Review

  2022cites this paper
• The potential of plant extracts in cell therapy

  2022cites this paper
• Application of telomere biology and telomerase in mesenchymal stem cells

  2022cites this paper
• TGFβ1-modified MSC-derived exosome attenuates osteoarthritis by inhibiting PDGF-BB secretion and H-type vessel activity in the subchondral bone.

  2022cites this paper
• Plants as a Source of Anticancer Agents: From Bench to Bedside

  2022cites this paper
• Tanshinone IIA improves cardiac function via regulating miR-499-5p dependent angiogenesis in myocardial ischemic mice.

  2022cites this paper
• Role of Wnt/β-catenin pathway in cardiac lineage commitment of human umbilical cord mesenchymal stem cells by zebularine and 2'-deoxycytidine.

  2022cites this paper
• Isolation and Characterization of Cat Olfactory Ecto-Mesenchymal Stem Cells

  2022cites this paper
• Reproductive and Developmental Toxicity Assessment of Human Umbilical Cord Mesenchymal Stem Cells in Rats

  2022cites this paper
• The hopes and hypes of plant and bacteria-derived cellulose application in stem cell technology

  2022cites this paper
• Chitosan hydrogel, as a biological macromolecule-based drug delivery system for exosomes and microvesicles in regenerative medicine: a mini review

  2022cites this paper
• Nanoparticles for Stem Cell Tracking and the Potential Treatment of Cardiovascular Diseases

  2021cites this paper
• TGF-β1-modified MSC-derived exosomal miR-135b attenuates cartilage injury via promoting M2 synovial macrophage polarization by targeting MAPK6

  2021cites this paper
• The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration

  2021cites this paper
• MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway

  2021cites this paper
• Pseudogenes in Cardiovascular Disease

  2021cites this paper
• Effect of gingival mesenchymal stem cell-derived exosomes on inflammatory macrophages in a high-lipid microenvironment.

  2021cites this paper
• Bioinspired Device Improves The Cardiogenic Potential of Cardiac Progenitor Cellst

  2021cites this paper
• Mesenchymal stem cells: Biological characteristics and application in disease therapy.

  2021cites this paper
• Capsaicin on stem cell proliferation and fate determination - a novel perspective.

  2021cites this paper
• Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics

  2021cites this paper
• The Role of non-coding RNA in Cardiac Repair and Regeneration after Myocardial Infarction

  2021cites this paper
• Cellular Technologies in Traumatology: from Cells to Tissue Engineering

  2021cites this paper
• The Progress of IPS Therapy on the Heart and Neural Disease

  2021cites this paper
• Herbal Extract from Codonopsis pilosula (Franch.) Nannf. Enhances Cardiogenic Differentiation and Improves the Function of Infarcted Rat Hearts

  2021cites this paper
• Extracellular Vesicles as Potential Theranostic Platforms for Skin Diseases and Aging

  2021cites this paper
• Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review

  2021cites this paper
• Adipose‐derived stem cells regulate metabolic homeostasis and delay aging by promoting mitophagy

  2021cites this paper
• Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases

  2021cites this paper
• Magnetic Particle Imaging: Current and Future Applications, Magnetic Nanoparticle Synthesis Methods and Safety Measures

  2021cites this paper
• Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea–Hypopnea Syndrome-Related Atherosclerosis

  2021cites this paper
• Elimination of residual undifferentiated induced pluripotent stem cells (iPSCs) using irradiation for safe clinical applications of iPSC-derived cardiomyocytes.

  2021cites this paper
• Hypoxic ucMSC-secreted exosomal miR-125b promotes endothelial cell survival and migration during wound healing by targeting TP53INP1

  2021cites this paper
• Bone-Marrow Stem Cells and Acellular Human Amniotic Membrane in a Rat Model of Heart Failure

  2021cites this paper
• Cortical Bone Stem Cell-Derived Exosomes' Therapeutic Effect On Myocardial Ischemia Reperfusion and Cardiac Remodeling.

  2021cites this paper
• Preclinical Advances of Therapies for Laminopathies

  2021cites this paper
• Mobile 5P-Medicine Approach for Cardiovascular Patients

  2021cites this paper
• Current Status of Stem Cell Therapy and Nanofibrous Scaffolds in Cardiovascular Tissue Engineering

  2021cites this paper
• Cellular Technologies in Traumatology: From Cells to Tissue Engineering

  2021cites this paper
• MicroRNAs and Exosomes: Cardiac stem cells in heart diseases

  2021cites this paper
• Stem-Cell-Based Cardiac Regeneration: Is There a Place For Optimism in the Future?

  2021cites this paper
• Magnetoelastic Materials for Monitoring and Controlling Cells and Tissues

  2021cites this paper
• Fate of hematopoietic stem cells determined by Notch1 signaling (Review)

  2021cites this paper
• The role of long non‐coding RNAs and circular RNAs in bone regeneration: Modulating miRNAs function

  2021cites this paper
• Triggering receptor expressed on myeloid cells-2 promotes survival of cardiomyocytes after myocardial ischemic injury through PI3K/AKT pathway.

  2021cites this paper
• From 2D To 3D, Advances of Technology and Instrumentation for Stem Cell Culture in Vitro

  2021cites this paper
• Prediction on Clopidogrel's Abnormal Behaviors and Pharmacobehavioral Economics

  2021cites this paper
• Adiponectin Improves Therapeutic E cacy of Mesenchymal Stem Cells by Enhancing Their Engraftment and Survival in Peri-infarct Myocardium Through AMPK Pathway

  2021cites this paper
• In vitro controlled release of extracellular vesicles for cardiac repair from poly(glycerol sebacate) acrylate-based polymers.

  2020cites this paper
• Interdisciplinary approaches to advanced cardiovascular tissue engineering: ECM-based biomaterials, 3D bioprinting, and its assessment

  2020cites this paper
• Synovial Mesenchymal Stem Cell-Derived EV-Packaged miR-31 Downregulates Histone Demethylase KDM2A to Prevent Knee Osteoarthritis

  2020cites this paper
• MicroRNA-338 in MSCs-derived exosomes inhibits cardiomyocyte apoptosis in myocardial infarction.

  2020cites this paper
• Lipopolysaccharide-stimulated bone marrow mesenchymal stem cells-derived exosomes inhibit H2O2-induced cardiomyocyte inflammation and oxidative stress via regulating miR-181a-5p/ATF2 axis.

  2020cites this paper
• Delivery Systems for Enhancing Oncolytic Adenoviruses Efficacy.

  2020cites this paper
• Chromatin‐modifying drugs and metabolites in cell fate control

  2020cites this paper
• Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages

  2020cites this paper
• Adiponectin Improves Therapeutic Efficacy of Mesenchymal Stem Cells by Enhancing Their Engraftment and Survival in Peri-infarct Myocardium Through AMPK Pathway CURRENT POSTED

  2020cites this paper